Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Cue Health Inc. functioned as a healthcare technology company, developing the Cue Health platform to provide individuals and healthcare providers with convenient and personalized access to lab-quality diagnostic tests, usable both at home and at the point-of-care. The platform also enabled on-demand telehealth consultations and offered treatment options for various health and wellness needs. Its core offering, the Cue Integrated Care platform, comprised essential hardware components like the Cue Health Monitoring System (featuring a reusable Cue Reader, a single-use Cue Cartridge, and a Cue Wand), sophisticated software including the cloud-based Cue Data and Innovation Layer for analytics, and virtual care delivery applications such as the Cue Health App and Cue Enterprise Dashboard. The platform also integrated with a broader ecosystem, connecting to electronic medical record systems, pharmacies, last-mile delivery services, clinician networks, and laboratories. Additionally, the company supplied COVID-19 testing kits. Founded in 2010 in San Diego, California, the firm was formerly known as Cue Inc. until its name change in December 2017. However, on May 28, 2024, Cue Health Inc. and its affiliates initiated voluntary liquidation by filing for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB